Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...

Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The pharmaceutical industry has long relied on a test that uses a protein called LAL taken from the blood of American ...

Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.

Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as ...

The NIH Clinical Center is struggling to carry out its mission of running clinical trials for the hardest-to-treat diseases ...

Americans are far too accepting of political control of health-related decisions when governments have no demonstrated ...

The Trump administration has asked a judge to toss out a lawsuit from three Republican-led states seeking to cut off ...

Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...

Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less ...